Haffner Energy decides to spin off SAF business
Sep 13, 2024 16:01 CESTJun 27, 2013 - French firm Cellectis (EPA:ALCLS) has managed to genetically reprogram diatoms, using its engineered nucleases, thus paving the way for new options for biofuel production from photosynthesis and carbon dioxide.
The genome engineering specialist said Wednesday it had engineered the genome of photosynthetic algae “with a view to producing biofuels”. It has generated a lipid-rich diatom and expects to unveil new opportunities in synthetic biology and especially biofuel production involving photosynthesis.
Cellectis is involved in the development and production of engineered site-specific endonucleases, which it defines as the most powerful approach in genome engineering. By targeting specific sequences within diatoms’ genome, these nucleases can be used to accurately insert, correct, or inactivate specific genes, it explained.
Haffner Energy decides to spin off SAF business
Sep 13, 2024 16:01 CESTIberdrola inaugurates 496-MW Saint-Brieuc wind farm offshore France
Sep 19, 2024 16:25 CESTFrench packaging group Albea agrees 12-MWp solar off-take deal
Sep 19, 2024 5:38 CESTWeekly renewables M&A round-up (Sep 9-13)
Sep 13, 2024 17:19 CESTEuropean wind turbine orders rise 11% in H1 2024 - WindEurope
Sep 12, 2024 14:33 CESTRenewables rise and Russian gas declines, says EC report
Sep 12, 2024 11:11 CEST